Masanori Funabashi Selected Research

21- hydroxy- 9beta,10alpha- pregna- 5,7- diene- 3- ol- 20- one

1/2020

A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanori Funabashi Research Topics

Disease

1	Neoplasms (Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020
1	Myocardial Infarction 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Stroke (Strokes) 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020

Drug/Important Bio-Agent (IBA)

1	Tyrosine Kinase InhibitorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	patritumab deruxtecanIBA 01/2022
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	phenylacetylglutamineIBA 01/2020
1	phenylacetylglycineIBA 01/2020
1	phenylacetic acid (phenylacetate)FDA Link 01/2020
1	21- hydroxy- 9beta,10alpha- pregna- 5,7- diene- 3- ol- 20- oneIBA 01/2020

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020